NCT06765226 Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
| NCT ID | NCT06765226 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abiomed Inc. |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-21 |
| Primary Completion | 2030-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-09-21 with a primary completion date of 2030-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Analysis of cell and protein deposits on the Impella Heart Pump.
Eligibility Criteria
Inclusion Criteria: * Patients with Impella 5.5 therapy and duration of support for ≥ 25 days OR Patients with Impella CP therapy and duration of support for \> 4 days Exclusion Criteria: * Age \< 18 years
Contact & Investigator
Pia Lanmüller, MD
PRINCIPAL INVESTIGATOR
Deutsches Herzzentrum der Charité
Frequently Asked Questions
Who can join the NCT06765226 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06765226 currently recruiting?
Yes, NCT06765226 is actively recruiting participants. Contact the research team at RA-PumpReturnEMailAr@ITS.JNJ.com for enrollment information.
Where is the NCT06765226 trial being conducted?
This trial is being conducted at Heidelberg, Germany, Düsseldorf, Germany, Dresden, Germany, Leipzig, Germany and 3 additional locations.
Who is sponsoring the NCT06765226 clinical trial?
NCT06765226 is sponsored by Abiomed Inc.. The principal investigator is Pia Lanmüller, MD at Deutsches Herzzentrum der Charité. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.